These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17169031)

  • 1. Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia.
    Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S134-5. PubMed ID: 17169031
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S119-21. PubMed ID: 17169024
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression and activation of complement protein and alveolar damage during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Tschang D; Wang SH; Zhang C; Liao CP; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S136-7. PubMed ID: 17169032
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia.
    Ray CA; Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S127-9. PubMed ID: 17169028
    [No Abstract]   [Full Text] [Related]  

  • 5. GM-CSF expression in the lung during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S124-6. PubMed ID: 17169027
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.
    Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Murakami Y; Matsufuji S; Lee CH
    J Biol Chem; 2009 Mar; 284(12):8174-84. PubMed ID: 19158080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival pathway signal transduction is reduced in alveolar macrophages during Pneumocystis pneumonia.
    Lasbury ME; Ray CA; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S130-1. PubMed ID: 17169029
    [No Abstract]   [Full Text] [Related]  

  • 8. Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia.
    Lasbury ME; Merali S; Durant PJ; Tschang D; Ray CA; Lee CH
    J Biol Chem; 2007 Apr; 282(15):11009-20. PubMed ID: 17314093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages.
    Zhang C; Wang SH; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S132-3. PubMed ID: 17169030
    [No Abstract]   [Full Text] [Related]  

  • 10. Caspase-9 as a target for Pneumocystis pneumonia therapy.
    Lasbury ME; Wang SH; Zhang C; Liao CP; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S138-9. PubMed ID: 17169033
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Ray CA; Tschang D; Schwendener R; Lee CH
    J Immunol; 2006 Jun; 176(11):6443-53. PubMed ID: 16709801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.
    Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
    J Eukaryot Microbiol; 1999; 46(5):149S. PubMed ID: 10519296
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis carinii factor responsible for reduced phagocytic activity in alveolar macrophages.
    Lasbury ME; Lin PM; Tschang D; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2003; 50 Suppl():641-2. PubMed ID: 14736197
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease in alveolar macrophage number during Pneumocystis carinii infection.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2003; 50 Suppl():630-1. PubMed ID: 14736191
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in alveolar macrophage number are early events in Pneumocystis carinii infection.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2001; Suppl():161S-162S. PubMed ID: 11906044
    [No Abstract]   [Full Text] [Related]  

  • 16. Syndecan-1 expression in the lung during Pneumocystis infection.
    Wang SH; Zhang C; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S122-3. PubMed ID: 17169026
    [No Abstract]   [Full Text] [Related]  

  • 17. Host defenses against Pneumocystis carinii in mice selectively depleted of CD4+ lymphocytes.
    Beck JM; Warnock ML; Kaltreider HB; Shellito JE
    Chest; 1993 Feb; 103(2 Suppl):116S-118S. PubMed ID: 8094045
    [No Abstract]   [Full Text] [Related]  

  • 18. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
    Lanken PN; Minda M; Pietra GG; Fishman AP
    Am J Pathol; 1980 Jun; 99(3):561-88. PubMed ID: 6966893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from Pneumocystis carinii pneumonia in dexamethasone-treated Wistar rats.
    Sukura A; Konttinen YT; Sepper R; Lindberg LA
    Eur Respir J; 1995 May; 8(5):701-8. PubMed ID: 7656938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage fluid from Pneumocystis carinii-infected rats inhibits phagocytosis in normal alveolar macrophages.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2001; Suppl():163S-164S. PubMed ID: 11906045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.